COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

FujiLAM Prospective Evaluation Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04089423
Recruitment Status : Recruiting
First Posted : September 13, 2019
Last Update Posted : March 17, 2020
Centre for Infectious Disease Research in Zambia
Infectious Diseases Institute, Uganda
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Swiss Tropical & Public Health Institute
Ifakara Health Institute
University of Cape Town
Viet-Tiep Hospital
National Tuberculosis Control Programme
Omega Diagnostics
Tuberculosis and Lung Disease Hospital in Hai Phong
Information provided by (Responsible Party):
Foundation for Innovative New Diagnostics, Switzerland

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2021